Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
Shamin Azwar, Heng Fong Seow, Maha Abdullah, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 854-854
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
Shumin Ouyang, Huaxuan Li, Linlin Lou, et al.
Redox Biology (2022) Vol. 52, pp. 102317-102317
Open Access | Times Cited: 241
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 58
Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
Asimina Zisi, Jiří Bártek, Mikael S. Lindström
Cancers (2022) Vol. 14, Iss. 9, pp. 2126-2126
Open Access | Times Cited: 52
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Dzohara Murillo, Carmen Huergo, Borja Gallego, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 208-208
Open Access | Times Cited: 33
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
William H. Gmeiner, Charles Chidi Okechukwu
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 257-272
Open Access | Times Cited: 23
5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity
Yingcui Yang, Mingqing Zhang, Yongdan Zhang, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1563-1563
Open Access | Times Cited: 21
The effective combination therapies with irinotecan for colorectal cancer
Yun Chai, Jingli Liu, Shuo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer
Yanping Gui, Xiaoping Qian, Youxiang Ding, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD‐mediated pyroptosis in colorectal cancer
Xin Guan, Ruiqi Liu, Bojun Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 6
FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction
Zhukai Chen, Jiacheng Xu, Kang Fang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines
A. V. Razumovskaya, M. O. Silkina, А. А. Полозников, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Beyond Chemotherapy: Exploring 5-FU Resistance and Stemness in Colorectal Cancer
Urmila Singh, Rekha Rani Kokkanti, Srinivas Patnaik
European Journal of Pharmacology (2025), pp. 177294-177294
Closed Access
Enhanced Drug Delivery of 5-Fluorouracil Using a GO-PVP-SA Nanocomposite for Targeted Colorectal Cancer Treatment
Mehrab Pourmadadi, Narges Ajalli, Mohammad Nouri, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access
Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment
Guillermo J. Valenzuela, Héctor R. Contreras, Katherine Marcelain, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1168-1168
Open Access
Computational Elucidation of Hub Genes and Pathways Correlated with the Development of 5-Fluorouracil Resistance in HCT 116 Colorectal Carcinoma Cell Line
Chun Hoe Tan, Siew‐Huah Lim, Kae Shin Sim
Biochemical Genetics (2025)
Open Access
CLMP increases 5-fluorouracil sensitivity in colorectal cancer through the inhibition of autophagy
Kun Yu, Hongjiang Pu, Xuan Zhang, et al.
Tissue and Cell (2025), pp. 102771-102771
Closed Access
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhani Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access
The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer
Zahra Kalaei, Reyhaneh Manafi‐Farid, Bentolhoda Rashidi, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Mitochondria in colorectal cancer stem cells - a target in drug resistance
Mateus de Almeida Rainho, Priscyanne Barreto Siqueira, Ísis Salviano Soares de Amorim, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 273-283
Open Access | Times Cited: 14
Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids
Marwa M. Abu‐Serie
Nanomedicine (2024) Vol. 19, Iss. 11, pp. 979-994
Closed Access | Times Cited: 5
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions
Samantha Sharma, Naresh Singh, Anita Turk, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 13, pp. 1815-1835
Open Access | Times Cited: 4
Interactions between Dietary Antioxidants, Dietary Fiber and the Gut Microbiome: Their Putative Role in Inflammation and Cancer
Camelia Munteanu, Betty Schwartz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8250-8250
Open Access | Times Cited: 4
The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B
Lixue Wang, Jinlong Chen, Qijun Chen, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 13
Evaluation of the role of ionic liquid as a modifier for carbon paste electrodes in the detection of anthracyclines and purine-pyrimidine-based anticancer agents
Isha Soni, Amisha Kumari, Gururaj Kudur Jayaprakash, et al.
Materials Research Express (2024) Vol. 11, Iss. 1, pp. 012005-012005
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top